The findings suggest that the combination of tocilizumab, atezolizumab, and FSRT was safe and well tolerated in patients with rGBM but did not achieve the pre-specified efficacy outcome.
Stephen J. Bagley, Mei-Yin C. Polley, R. Kotecha et al.· International Journal of Rad...· 0 citations
Postoperative radiotherapy is commonly used after resection of brain metastases, but durable local control with a low rate of adverse events (AEs) remains challenging. This systematic review summarizes outcomes and AEs of postoperative stereotactic interventional radiotherapy (S-IRT; brachytherapy) for resected brain m...
M. Bilski, F. Mastroleo, I. Baranowska et al.· La radiologia medica· 0 citations
This review summarizes the current biologic and clinical framework of BM, including molecular divergence from the primary tumor, the evolution of prognostic models, and the growing role of brain-specific risk stratification in treatment planning.
Z. Sarfraz, R. Kotecha, Arun Maharaj et al.· Neurotherapeutics· 1 citation
SBRT for rib metastases from prostate cancer was associated with high LC, pain relief, and low observed toxicity in this retrospective real-world cohort, and GTV-only contouring may be feasible in carefully selected patients staged and planned with PSMA-PET/CT.
M. Bilski, F. Mastroleo, I. Banaszek et al.· Therapeutic Advances in Medi...· 0 citations
In this prospective registry, resection followed by GammaTile brachytherapy achieved excellent local control, and manageable toxicity in newly diagnosed BM, supporting that GammaTile brachytherapy is a promising strategy for large or symptomatic BM.
Ruchit P. Jain, Z. Sarfraz, Mukesh Roy et al.· Neuro-Oncology Advances· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
